Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus. Read more about Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus.
Genetic, structural, and functional analysis of pathogenic variations causing methylmalonyl-CoA epimerase deficiency. Read more about Genetic, structural, and functional analysis of pathogenic variations causing methylmalonyl-CoA epimerase deficiency.
Open notebook science can maximize impact for rare disease projects. Read more about Open notebook science can maximize impact for rare disease projects.
Ideation and implementation of an open science drug discovery business model - M4K Pharma. Read more about Ideation and implementation of an open science drug discovery business model - M4K Pharma.
New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis. Read more about New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis.
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al. Read more about Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.
SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK). Read more about SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK).
Teneurin C-Terminal Associated Peptide (TCAP)-1 and Latrophilin Interaction in HEK293 Cells: Evidence for Modulation of Intercellular Adhesion. Read more about Teneurin C-Terminal Associated Peptide (TCAP)-1 and Latrophilin Interaction in HEK293 Cells: Evidence for Modulation of Intercellular Adhesion.
Structural insights into SETD3-mediated histidine methylation on β-actin. Read more about Structural insights into SETD3-mediated histidine methylation on β-actin.
Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity. Read more about Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity.
